Searched for
OKASA PHARMA
Cipla shares in focus as promoters Samina and Rumana Hamied offload 1.72% stake for Rs 2,111 croreCipla shares are in focus today after Samina Hamied and Rumana Hamied, promoters of the pharmaceutical company, exited by selling their 1.7...- Promoters Samina and Rumana Hamied exit Cipla; sell 1.72 pc stake for Rs 2,111 croreSamina Hamied and Rumana Hamied, promoters of drug major Cipla, on Monday exited the pharmaceutical company by selling their 1.72 per cent ...
- Cipla shares in focus on Rs 2,000 crore likely block dealCipla's shares are likely to attract attention on Monday as the company's promoters may sell up to a 1.72% stake through block deals. The o...
- Cipla promoters to sell 1.72% stake in likely block deal worth Rs 2,000 crore: ReportCipla promoters are likely to sell up to 1.72% stake via a block deal at Rs 1,442 per share, a 6% discount to the current price. This follo...
- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Cipla promoters sell 2.53% stake for Rs 2,751 crore"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...
- Cipla promoters sell 2.53% stake for around Rs 2,600 crorePromoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquid...
- Stocks in news: PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, CiplaBenchmark equities surged for the third consecutive day on Tuesday. PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, and Cipla...
- Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...
- Promoter entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore: ReportPromoters of drugmaker Cipla are expected to offload 2.53% of their stake in a block deal worth Rs 2637 crore on Wednesday, according to so...
- Promoter group entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore via block deals: ReportThe price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.
- Hamsons buys 21% stake in Okasa PharmceuticalsWhile Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...
- Hamied family company buys out minority shareholders in OkasaThe acquisition is part of a two-way transaction under which the Yusuf Khwaja Hamied-run Cipla's wholly-owned arm Medispray Laboratories co...
- Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
- Sensex, Nifty hit record high; top ten stocks in focusThe Nifty was at 8,141.50 up 54 points or 0.67 per cent. It touched an intraday record high of 8,146.55 and a low of 8126.15.
- Cipla rallies over 1% on acquisition plans for Rs 100 croreAt 09:35 a.m.; Cipla was trading 0.6 per cent higher at Rs 560.75. It hit a low of Rs 559 and a high of Rs 565.40 in trade today.
- Ten stocks in focus in Monday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Cipla to acquire two units in Goa and Maharashtra for Rs100 croreEntities controlled by relatives of the promoters hold majority interest in the companies, which own the aforesaid undertakings, it added.
- India rejects Abbot lab's patent application for HIV drugIndia has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
Load More
